共 50 条
- [2] Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension[J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 718 - 722Ruperto, NicolinoLovell, Daniel J.Cuttica, RubenWoo, PatriciaMeiorin, SilviaWouters, CarineSilverman, Earl D.Balogh, ZsoltHenrickson, MichaelDavidson, JoyceFoeldvari, IvanImundo, LisaSimonini, GabrieleOppermann, JoachimXu, StephenShen, Yaung-KaungVisvanathan, SudhaFasanmade, AdedigboMendelsohn, AlanMartini, AlbertoGiannini, Edward H.
- [3] Long-term efficacy & safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: Findings from an open-label treatment extension.[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S632 - S632Lovell, D. J.Ruperto, N.Cuttica, R.Woo, P.Espada, G.Wouters, C.Silverman, E. D.Balogh, Z.Henrickson, M.Davidson, J.Foeldvari, I.Imundo, L.Simonini, G.Oppermann, J.Shen, Y. K.Visvanathan, S.Fasanmade, A.Mendelsohn, A.Giannini, E. H.Martini, A.
- [4] 2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension[J]. Pediatric Rheumatology, 6 (Suppl 1)N RupertoDJ LovellR CutticaP WooG EspadaC WoutersED SilvermanZ BaloghM HenricksonJ DavidsonI FoeldvariL ImundoG SimoniniJ OppermannYK ShenS VisvanathanA FasanmadeA MendelsohnA MartiniEH Giannini
- [5] Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 554 - 562Silverman, ESpiegel, LHawkins, DPetty, RGoldsmith, DSchanberg, LDuffy, CHoward, PStrand, V
- [6] Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis - Interim results from an ongoing multicenter, open-label, extended-treatment trial[J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (01): : 218 - 226Lovell, DJGiannini, EHReiff, AJones, OYSchneider, ROlson, JCStein, LDGedalia, AIlowite, NTWallace, CALange, MFinck, BKBurge, DJ
- [7] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study[J]. ANNALS OF THE RHEUMATIC DISEASES, 2024,Brunner, Hermine, IAkikusa, Jonathan D.Al-Abadi, EslamBohnsack, John F.Boteanu, Alina LucicaChedeville, GaelleCuttica, RubenDe La Pena, WendyJung, LawrenceKasapcopur, OzgurKobusinska, KatarzynaSchulert, Grant S.Neiva, ClaudiaRivas-Chacon, RafaelRodriguez, Juan Cruz RizoVazquez-Del Mercado, MonicaWagner-Weiner, LindaWeiss, Jennifer E.Wouters, CarinePosner, HollyWouters, AnnChang, ChengWhite, ClaireKanik, KeithLiu, ShixueMartini, AlbertoLovell, Daniel J.Ruperto, Nicolino
- [8] Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan[J]. MODERN RHEUMATOLOGY, 2012, 22 (05) : 720 - 726Mori, MasaakiTakei, SyujiImagawa, TomoyukiImanaka, HiroyukiNerome, YasuhitoHiguchi, RumikoKawano, YoshifumiYokota, ShumpeiSugiyama, NorikoYuasa, HirotoshiFletcher, TraceyWajdula, Joseph S.
- [9] Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 59 - 59Taylor, P.Genovese, M.Keystone, E.Schlichting, D.Beattie, S.Macias, W.Lundmark, J.
- [10] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDY[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 65 - 66Taylor, P.Genovese, M. C.Keystone, E.Schlichting, D.Beattie, S.Macias, W.